跳至主要内容
临床试验/NCT02389699
NCT02389699Unknown不适用

Comparison of the Efficacy of Intra-operative Radiation Therapy After Conserving Surgery With Post-operative Whole Breast Radiotherapy for Women With Ductal Carcinoma in Situ

Liao Ning1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2014年6月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
74
试验地点
1
主要终点
ipsilateral breast tumor recurrence rate after surgery within five years

研究概览

简要总结

Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation during surgery followed by external-beam radiation to the entire breast may kill more tumor cells.The clinical trial is conducting to compare the effectiveness of radiation therapy during surgery and whole-breast radiation therapy in treating women who have undergone breast-conversing surgery for Intermediate or high grade ductal carcinoma in situ breast cancer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Tumor diameter < 5 cm
  • Intermediate or high grade ductal carcinoma in situ
  • Informed consent

排除标准

  • No informed consent
  • Tumor size > 3,5 cm
  • Low grade ductal carcinoma in situ
  • Invasive carcinoma
  • No indication for a boost

结局指标

主要结局

ipsilateral breast tumor recurrence rate after surgery within five years

时间窗: Within 5 years after surgery

Within 5 years after surgery,we should evaluate ipsilateral breast tumor recurrence and Disease free survival as the most important outcome measure

Disease free survival after surgery within five years

时间窗: Within 5 years after surgery

Within 5 years after adjuvant chemotherapy,we should evaluateDisease free survival(DFS) rates as thet important outcome measure.

次要结局

  • Overall survival after surgery within ten years(Within ten years after surgery)

研究者

发起方
Liao Ning
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Liao Ning

Guangdong Academy of Medical Sciences

Guangdong Academy of Medical Sciences

研究点 (1)

Loading locations...

相似试验